Ad is loading...
GCTMX
Price
$12.27
Change
-$0.10 (-0.81%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

GCTMX vs VTSNX

Header iconGCTMX vs VTSNX Comparison
Open Charts GCTMX vs VTSNXBanner chart's image
Goldman Sachs International T/M Eq C
Price$12.27
Change-$0.10 (-0.81%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
GCTMX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCTMX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTMX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. GCTMX (918M). VTSNX pays higher dividends than GCTMX: VTSNX (3.29) vs GCTMX (1.19). GCTMX was incepted earlier than VTSNX: GCTMX (17 years) vs VTSNX (14 years). GCTMX is a more actively managed with annual turnover of: 132.00 vs. VTSNX (4.00). GCTMX has a lower initial minimum investment than VTSNX: GCTMX (1000) vs VTSNX (5000000). GCTMX annual gain was more profitable for investors over the last year : 13.42 vs. VTSNX (10.92). GCTMX return over 5 years is better than : 31.41 vs. VTSNX (15.91).
GCTMXVTSNXGCTMX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD5.8674.535129%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets918M442B0%
Annual Yield % from dividends1.193.2936%
Returns for 1 year13.4210.92123%
Returns for 3 years5.83-5.86-99%
Returns for 5 years31.4115.91197%
Returns for 10 years58.1529.81195%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals